Delivery Order SPE2DB24D2216-SPE2DB25FGPPA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for 84 tablets of Xermelo 250 mg on July 23, 2025, with completion expected by August 13, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement fulfilling pharmaceutical supply requirements for military healthcare systems. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for Xermelo 250 mg tablets (84-count supply) on August 14, 2025, with completion targeted for September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $5,526.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xermelo 250 mg tablets (84-count units). This non-set-aside competitive award is scheduled for completion by August 11, 2025, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $9,295.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the procurement of 84 boxes of Xermelo 250 mg tablets. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 21, 2023 in support of the Defense Logistics Agency's logistics and procurement operations. No set aside designation or subcontractors were identified. The delivery order was awarded under an existing...
- This federal contract award, valued at $5,526.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XERMELO 250 MG TABLET 84S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of March 31, 2025 and was awarded on March 10, 2025. This contract award is associated with a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XERMELO 250 MG TABLET 84S. The contract has a firm fixed price of $5,526.76 and a period of performance through July 23, 2025. This contract is not designated as a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,775.56 Firm Fixed Price Delivery Order is for the provision of 4566736117 XERMELO 250 MG TABLET 84S, a specialty medication. The contract has an ultimate completion date of January 8, 2025 and was awarded on December 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XERMELO 250 MG TABLET 84S, a pharmaceutical product. The contract has a ceiling value of $5,526.76 and is a firm fixed-price contract. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XERMELO 250 MG TABLET 84S, a pharmaceutical product, with a ceiling value of $5,526.76 and a period of performance ending on June 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- The federal contract award is a delivery order with a firm fixed price of $5,526.76 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XERMELO 250 MG TABLET 84S to the Defense Logistics Agency, a defense agency. The award has an ultimate completion date of July 28, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPPADelivery Order
This delivery order, awarded August 18, 2025, to AmerisourceBergen Drug Corp provides 84 tablets of Xermelo 250 mg with a ceiling value of $5,526.76. The contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) without a set-aside designation, indicating open competitive procurement. The pharmaceutical product will be delivered to a location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal vendor for military and veteran healthcare procurement. The company holds extensive federal contract authority to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Xermelo represents one of numerous competitively awarded transactions through the company's prime indefinite delivery vehicle, demonstrating its capability to fulfill diverse federal medical supply requirements through flexible contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 8/18/25 |